GoodRx Holdings, Inc. (GDRX) earnings date
Nov 10, 2026, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead. This date passed 9 days ago with no results filing on EDGAR yet.
- Fiscal period
- Q3 FY2026
- Confidence
- 23% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 37 days, typically, give or take 10 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q2 FY2026 | Wed, Aug 5, 2026 | after close | 36 | 8-K |
| Q1 FY2026 | Wed, May 6, 2026 | after close | 36 | 8-K |
| Q4 FY2025 | Wed, Feb 25, 2026 | after close | 56 | 8-K |
| Q3 FY2025 | Tue, Nov 4, 2025 | after close | 35 | 8-K |
| Q2 FY2025 | Wed, Aug 6, 2025 | after close | 37 | 8-K |
| Q1 FY2025 | Wed, May 7, 2025 | after close | 37 | 8-K |
| Q4 FY2024 | Thu, Feb 27, 2025 | before open | 58 | 8-K |
| Q3 FY2024 | Thu, Nov 7, 2024 | before open | 38 | 8-K |
What they guided beta
| Q2 FY2026 | "EX-99.1 2 gdrxq226-exx991pressrelease.htm EX-99.1 GDRX Q2'26 - EX-99.1 (Press Release) Exhibit 99.1 GOODRX REPORTS SECOND QUARTER 2026 RESULTS Pharma Direct and Subscription Revenue Increased 76% and 39% , Respectively, Year-Over-Year Company Raises Full-Year 2026 Revenue and Adjusted EBITDA Expectations SANTA MONICA, Calif. -- ( August 5, 2026 ) -- GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the second quarter of 2026 ." exhibit |
| Q2 FY2026 | "Exhibit 99.1 Guidance Management is raising its full-year 2026 guidance as follows : $ in millions FY 2026 FY 2025 YoY Change Revenue $790 - $805 $796.9 (1%) - 1% Adjusted EBITDA 2 $240 - $250 “We exceeded our expectations in the second quarter, with Pharma Direct revenue increasing 76% year-over-year and subscription revenue increasing 39% year-over-year,” said Justin Fengler , incoming Chief Financial Officer and current Chief Strategy & Operations Officer of GoodRx." exhibit |
| Q2 FY2026 | "“Based on our strong first-half performance, we are raising our full-year revenue and Adjusted EBITDA guidance.” 2." exhibit |
| Q2 FY2026 | "Investor Conference Call and Webcast GoodRx management will host a conference call and webcast tomorrow, August 6, 2026, at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook." exhibit |
| Q1 FY2026 | "EX-99.1 2 gdrxq126-exx991pressrelease.htm EX-99.1 GDRX Q1'26 - EX-99.1 (Press Release) Exhibit 99.1 GOODRX REPORTS FIRST QUARTER 2026 RESULTS Pharma Direct Revenue Increased 82% Year-Over-Year in the First Quarter Company Raises Full Year 2026 Revenue and Adjusted EBITDA Expectations SANTA MONICA, Calif. -- ( May 6, 2026 ) -- GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2026 ." exhibit |
| Q1 FY2026 | "Guidance For the full year 2026, management is anticipating the following : $ in millions FY 2026 FY 2025 YoY Change Revenue $765 - $785 $796.9 (4%) - (1%) Adjusted EBITDA 2 > $235 “We exceeded our expectations in the first quarter, driven by strong execution across the business,” said Chris McGinnis, Chief Financial Officer and Treasurer of GoodRx." exhibit |
| Q1 FY2026 | "We are raising our full year guidance and remain focused on sustaining growth and maintaining strong margins.” 2." exhibit |
| Q1 FY2026 | "Investor Conference Call and Webcast GoodRx management will host a conference call and webcast tomorrow, May 7, 2026 , at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/GDRX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/GDRX
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/GDRX/"><img src="https://veritasdata.dev/embed/GDRX.svg" alt="GDRX earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/GDRX/)
Script
<script async src="https://veritasdata.dev/embed/GDRX.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/GDRX"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.